69$/KG
liposomal Glycine-Iron 80% is a high-purity, liposomal-encapsulated form of ferrous bisglycinate—a fully chelated iron complex in which each ferrous iron ion (Fe²⁺) is bound to two glycine molecules, forming a stable, neutral double-amino acid chelate ring structure. This chelated structure protects iron from dietary inhibitors and is absorbed intact through peptide transport pathways on enterocytes, bypassing the pH-dependent DMT1 pathway used by conventional iron salts. Liposomal encapsulation within a phospholipid bilayer further shields the iron-glycine chelate from gastric acid and food inhibitors, minimizes gastrointestinal irritation, and enables lymphatic absorption for rapid, efficient systemic delivery. This water-dispersible powder is standardized to ≥80% ferrous bisglycinate content, exhibits a light to dark greenish powder appearance, and is suitable for capsules, functional beverages, and nutritional formulations targeting iron deficiency anemia, hemoglobin formation, and Energy Metabolism. Each batch is HPLC-standardized and quality-tested for purity, identity, and elemental iron content.
Product Detailed Description
Liposomal Glycine-Iron 80% is a premium-grade dietary supplement ingredient delivering ferrous bisglycinate in an advanced liposomal delivery system. Ferrous bisglycinate, also known as iron bisglycinate or ferrous glycinate, is a fully reacted amino acid chelate in which a central ferrous iron ion is covalently bonded to the alpha-amino and carboxylate groups of two glycine molecules. This chelation process results in the formation of two stable, five-membered heterocyclic rings—a structural feature fundamental to its enhanced bioavailability and tolerability.
Iron is an essential mineral required for hemoglobin synthesis, oxygen transport, electron transfer, and numerous enzymatic reactions. Conventional iron supplements—particularly ferrous sulfate and ferrous fumarate—exhibit poor bioavailability and frequently cause gastrointestinal side effects including nausea, cramping, constipation, and dark stools. Ferrous bisglycinate addresses these limitations through its chelated structure and dual absorption pathway, while liposomal encapsulation provides an additional layer of protection and delivery enhancement.
Ferrous bisglycinate already offers superior bioavailability and gastrointestinal tolerance compared to conventional iron salts. A systematic review and meta-analysis of 17 randomized controlled trials demonstrated that ferrous bisglycinate supplementation resulted in higher hemoglobin concentrations in pregnant women compared with other iron supplements and significantly fewer gastrointestinal adverse events.
Liposomal encapsulation further enhances its performance through a biomimetic phospholipid bilayer that protects the iron-chelate complex during digestive transit and facilitates efficient cellular delivery.
Liposomal encapsulation provides three critical advantages:
1. Gastric Protection — The phospholipid bilayer shields the iron-glycine chelate from gastric acid degradation and interaction with dietary inhibitors including phytates, tannins, and calcium, preserving its intact structure until reaching optimal absorption sites in the small intestine.
2. Enhanced Absorption via Lymphatic Pathway — Liposomal iron utilizes endocytosis to enter cells directly, bypassing the DMT1 absorption ceiling entirely. liposomes also utilize a lymphatic absorption route, allowing rapid, efficient results. The lipid bilayer protects against acid and food inhibitors, with bioavailability 3 to 5 times higher than ordinary iron.
3. Zero Gut Contact — Minimized Side Effects — Liposomal encapsulation minimizes direct contact between iron and the gastrointestinal mucosa, preventing the Fenton reaction that generates free radicals and causes nausea, cramping, and constipation. The liposomal formulation achieves a high encapsulation efficiency of 87.42% and a loading capacity of 71%.
| Field | Details |
|---|---|
| Product Name | Liposomal Glycine-Iron 80% |
| CAS No. | 20150-34-9 |
| Active Ingredient | Ferrous Bisglycinate (Iron Bisglycinate Chelate) |
| Assay Method | RP-HPLC with post-column derivatization using PAR reagent for Fe(II) detection; ICP-MS for elemental iron content and heavy metal analysis; FTIR for chelation structure confirmation; DLS for particle size distribution; TEM for liposome vesicle structure confirmation |
| Purity | ≥ 80% ferrous bisglycinate; ≥ 20% elemental iron |
| Appearance / Color | Light to dark greenish powder |
| Dosage Form | Liposomal powder, water-dispersible |
| Recommended Dosage | 25–75 mg elemental iron per day for maintenance; 100–200 mg per day for iron deficiency; 1–2 capsules daily with food |
| Application | Iron deficiency anemia, hemoglobin formation, oxygen transport, energy metabolism, cognitive function, immune support, pregnancy support |
| Extract Source | Synthetic chelation (ferrous iron bound to two glycine molecules via proprietary chelation process) |
| Molecular Formula | C₄H₈FeN₂O₄ |
| Molecular Weight | 203.96 g/mol |
| Lead Time | In stock: 3–5 business days; Bulk/custom orders: 2–3 weeks |
| Shipping Method | International Express (FedEx / DHL / UPS); air and sea freight available; worldwide shipping including remote areas |
| Storage | Cool, dry place away from direct sunlight and moisture; keep container tightly sealed. Protect from light and heat |
High Purity — Standardized to ≥80% ferrous bisglycinate by HPLC, ensuring consistent active content and ≥20% elemental iron.
Fully Chelated Structure — Each ferrous iron ion is bound to two glycine molecules, creating a stable ring-like chelate structure that protects iron from dietary inhibitors.
Dual Absorption Pathway — Absorbed intact through peptide transporters on enterocytes, bypassing the pH-dependent DMT1 pathway used by ionic iron salts.
Superior Bioavailability — Studies demonstrate 2–4 times greater absorption compared to ferrous sulfate on a milligram-for-milligram basis.
Liposomal Enhancement — Phospholipid bilayer encapsulation achieves 87.42% encapsulation efficiency, 153.8 nm particle size, and −61.22 mV zeta potential, delivering 3–5 times higher absorption than conventional iron.
Gentle on Digestion — Because iron remains chelated through the gastric environment, it does not generate free ferrous ions that catalyze Fenton reactions and cause nausea, cramping, and constipation.
Water-Dispersible — Suitable for capsules, tablets, powder drink mixes, and functional beverages.
Batch Traceability — Complete COA, HPLC chromatogram, FTIR identity confirmation, and elemental iron assay data provided for each batch.
| Application | Recommended Usage | Notes |
|---|---|---|
| Capsules / Tablets | 25–75 mg elemental iron per serving | Take with food for optimal tolerance; can be taken with meals without reduced absorption |
| Functional Beverages | 15–30 mg per 250 mL | Water-dispersible; no metallic taste |
| Powdered Drink Mixes | 25–75 mg per sachet | Blend with vitamin C for enhanced absorption |
| Pregnancy Support Formulas | 30–60 mg per serving | Ferrous bisglycinate is better tolerated and improves hemoglobin in pregnant women |
| Pediatric / Sensitive Stomach Formulas | 10–25 mg per serving | Gentle on the stomach; minimizes GI side effects |
Clinical studies and commercial products commonly recommend 25–75 mg of elemental iron per day for maintenance in healthy adults and 100–200 mg per day for iron deficiency. A typical dosing regimen of 1–2 capsules daily provides approximately 25–50 mg elemental iron per serving. Ferrous bisglycinate can be taken with meals without the typical reduction in absorption seen with ionic iron forms, offering greater flexibility in dosing. Co-supplementation with vitamin C further enhances absorption. Iron status should be monitored through ferritin and transferrin saturation to guide dosing.
Stock Orders: 3–5 business days after payment confirmation.
Bulk / Custom Orders: 2–3 weeks, depending on quantity and customization requirements.
Shipping Methods: International Express (FedEx, DHL, UPS), air freight, and sea freight.
Coverage: Worldwide shipping, including remote areas.
Iron Bisglycinate Encyclopedia — Scientific Background
Ferrous bisglycinate, also known as iron bisglycinate or iron glycinate, is a chelated form of iron in which a ferrous iron ion is covalently bonded to the alpha-amino and carboxylate groups of two glycine molecules. This chelation process results in the formation of two stable, five-membered heterocyclic rings, creating a neutral complex with a low molecular weight of approximately 204 Da.
| Property | Value |
|---|---|
| CAS No. | 20150-34-9 |
| Molecular Formula | C₄H₈FeN₂O₄ |
| Molecular Weight | 203.96 g/mol |
| Appearance | Light to dark greenish powder |
| Odor | Virtually odorless |
| Solubility | Poorly soluble in water; soluble in aqueous acid |
| Elemental Iron | ≥ 20% (theoretical: 20.3%) |
The term “chelate” derives from the Greek word “chele,” meaning crab claw, referring to the pincer-like manner in which the amino acid glycine binds to the mineral ion. In ferrous bisglycinate, two glycine molecules coordinate with a central ferrous iron ion through their amino and carboxyl groups, forming two stable five-membered rings. This chelate structure is confirmed through FT-IR spectroscopy testing, which identifies characteristic absorption peaks associated with the Fe–N and Fe–O bonds.
Ferrous bisglycinate is absorbed intact through the intestinal mucosa via peptide transport pathways rather than exclusively through the conventional DMT1 pathway used by ionic iron. This dual absorption mechanism provides significantly higher bioavailability while bypassing many of the factors that typically inhibit iron absorption, including phytates, tannins, calcium, and fiber.
Because the chelate remains intact through the gastric environment and is absorbed as a whole complex, it does not generate free ferrous ions that catalyze Fenton reactions in the intestinal mucosa. This is the primary mechanism behind the nausea, cramping, constipation, and dark stools commonly experienced with ferrous sulfate and ferrous fumarate.
Iron is an essential trace mineral required for numerous physiological processes:
Hemoglobin Synthesis — Iron is the central atom in the heme group of hemoglobin, enabling oxygen transport from the lungs to tissues
Oxygen Transport — Iron-containing myoglobin facilitates oxygen storage and transport in muscle tissue
Electron Transfer — Iron-sulfur clusters and heme groups participate in mitochondrial electron transport chain reactions
Enzymatic Reactions — Iron is a cofactor for numerous enzymes involved in DNA synthesis, neurotransmitter production, and immune function
Energy Metabolism — Iron-containing cytochromes are essential for ATP production
Hemoglobin and Ferritin
A systematic review and meta-analysis of 17 randomized controlled trials evaluated the effects of ferrous bisglycinate supplementation on hemoglobin and ferritin concentrations. Compared with other iron supplements, supplementation with ferrous bisglycinate for 4–20 weeks resulted in higher hemoglobin concentrations in pregnant women and fewer reported gastrointestinal adverse events.
Bioavailability
In a preclinical study using iron-deficient rats, all iron supplements—including ferrous bisglycinate and liposomal iron—reversed iron deficiency within 14 days without adverse gastrointestinal effects. Studies demonstrate that ferrous bisglycinate achieves 2–4 times greater absorption compared to ferrous sulfate on a milligram-for-milligram basis.
Gastrointestinal Tolerability
Ferrous bisglycinate is generally well-tolerated with significantly fewer side effects than conventional iron supplements. Because the iron remains chelated through the gastric environment, it does not generate free ferrous ions that cause gastrointestinal irritation.
Liposomal encapsulation of ferrous bisglycinate provides an additional layer of protection and delivery enhancement beyond the chelation itself. The phospholipid bilayer surrounds the iron-glycine complex, forming a shield that protects it from harsh conditions including gastric acid and enzymatic degradation.
The liposomal delivery system achieves a remarkably high encapsulation efficiency of 87.42% and a loading capacity of 71%. Particle size analysis confirms nanoscale dimensions of approximately 153.8 nm with a narrow polydispersity index, and a zeta potential of −61.22 mV indicates excellent colloidal stability. The liposomal formulation demonstrates 3 to 5 times higher absorption compared to conventional iron salts, with a shelf life exceeding 3 years and heat stability at 105°C.
Ferrous bisglycinate is generally well tolerated and is known for its exceptional gastrointestinal safety profile. It does not cause the constipation, nausea, or metallic taste frequently associated with conventional iron salts. Iron status should be monitored through ferritin and transferrin saturation to guide dosing, as even well-tolerated forms should not be supplemented without confirmed deficiency due to the risks of iron overload. Ferrous bisglycinate is safe for use by pregnant and lactating women, teenagers, and adults. Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.
This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.
69$/KG
RELATED
RELATED
RELATED
RELATED
This website uses cookies to ensure you get the best experience on our website.
Comment
(0)